-
A287667-5mgPotent and selective ERK5 inhibitor.
-
A287809-100mgPotent TGF-βRI inhibitor.
-
A287809-10mgPotent TGF-βRI inhibitor.
-
A287809-1mgPotent TGF-βRI inhibitor.
-
A287809-25mgPotent TGF-βRI inhibitor.
-
A287809-50mgPotent TGF-βRI inhibitor.
-
A287809-5mgPotent TGF-βRI inhibitor.
-
A288808-100mgProduct Describtion:AZ13705339 is a highly potent and selective PAK1 inhibitor with IC50s of 0.33 nM and 59 nM for PAK1 and pPAK1, respectively. AZ13705339 has binding affinities to PAK1 and PAK2, with Kds of 0.28 nM and 0.32 nM, respectively.
-
A288808-10mgProduct Describtion:AZ13705339 is a highly potent and selective PAK1 inhibitor with IC50s of 0.33 nM and 59 nM for PAK1 and pPAK1, respectively. AZ13705339 has binding affinities to PAK1 and PAK2, with Kds of 0.28 nM and 0.32 nM, respectively.
-
A288808-25mgProduct Describtion:AZ13705339 is a highly potent and selective PAK1 inhibitor with IC50s of 0.33 nM and 59 nM for PAK1 and pPAK1, respectively. AZ13705339 has binding affinities to PAK1 and PAK2, with Kds of 0.28 nM and 0.32 nM, respectively.
-
A288808-50mgProduct Describtion:AZ13705339 is a highly potent and selective PAK1 inhibitor with IC50s of 0.33 nM and 59 nM for PAK1 and pPAK1, respectively. AZ13705339 has binding affinities to PAK1 and PAK2, with Kds of 0.28 nM and 0.32 nM, respectively.
-
A288808-5mgProduct Describtion:AZ13705339 is a highly potent and selective PAK1 inhibitor with IC50s of 0.33 nM and 59 nM for PAK1 and pPAK1, respectively. AZ13705339 has binding affinities to PAK1 and PAK2, with Kds of 0.28 nM and 0.32 nM, respectively.